JANUET 50/850 MG TABLETS

Country: Израел

Језик: Енглески

Извор: Ministry of Health

Активни састојак:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Доступно од:

MERCK SHARP & DOHME ISRAEL LTD

АТЦ код:

A10BA02

Фармацеутски облик:

TABLETS

Пут администрације:

PER OS

Произведен од:

MERCK SHARP & DOHME CORP., USA

Терапеутска група:

METFORMIN

Терапеутске индикације:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Датум одобрења:

2008-12-01